202 related articles for article (PubMed ID: 16905120)
21. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
Besch R; Berking C; Kammerbauer C; Degitz K
Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
[TBL] [Abstract][Full Text] [Related]
23. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
24. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy.
Saldanha RG; Molloy MP; Bdeir K; Cines DB; Song X; Uitto PM; Weinreb PH; Violette SM; Baker MS
J Proteome Res; 2007 Mar; 6(3):1016-28. PubMed ID: 17330942
[TBL] [Abstract][Full Text] [Related]
25. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
[TBL] [Abstract][Full Text] [Related]
26. Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1.
Jamaluddin MS
Biochem Biophys Res Commun; 2006 Sep; 348(2):618-27. PubMed ID: 16893520
[TBL] [Abstract][Full Text] [Related]
27. Urokinase receptor variants in tissue and body fluids.
Høyer-Hansen G; Lund IK
Adv Clin Chem; 2007; 44():65-102. PubMed ID: 17682340
[TBL] [Abstract][Full Text] [Related]
28. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
Kanse SM; Chavakis T; Al-Fakhri N; Hersemeyer K; Monard D; Preissner KT
J Cell Sci; 2004 Jan; 117(Pt 3):477-85. PubMed ID: 14679304
[TBL] [Abstract][Full Text] [Related]
30. Physical association of uPAR with the alphaV integrin on the surface of human NK cells.
Gellert GC; Goldfarb RH; Kitson RP
Biochem Biophys Res Commun; 2004 Mar; 315(4):1025-32. PubMed ID: 14985115
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
Stillfried GE; Saunders DN; Ranson M
Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
[TBL] [Abstract][Full Text] [Related]
32. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function.
Simon DI; Wei Y; Zhang L; Rao NK; Xu H; Chen Z; Liu Q; Rosenberg S; Chapman HA
J Biol Chem; 2000 Apr; 275(14):10228-34. PubMed ID: 10744708
[TBL] [Abstract][Full Text] [Related]
33. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
34. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry.
Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M
Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282
[TBL] [Abstract][Full Text] [Related]
35. Variability in the expression of urokinase receptor (CD87) mutants on cells: relevance to cell adhesion.
Kanse SM; Chavakis T; Kuo A; Bdeir K; Cines DB; Preissner KT
Cell Biochem Funct; 2004; 22(4):257-64. PubMed ID: 15248186
[TBL] [Abstract][Full Text] [Related]
36. Urokinase receptor (uPAR) regulates complement receptor 3 (CR3)-mediated neutrophil phagocytosis.
Pliyev BK; Arefieva TI; Menshikov MY
Biochem Biophys Res Commun; 2010 Jun; 397(2):277-82. PubMed ID: 20580686
[TBL] [Abstract][Full Text] [Related]
37. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.
Sitrin RG; Todd RF; Albrecht E; Gyetko MR
J Clin Invest; 1996 Apr; 97(8):1942-51. PubMed ID: 8621779
[TBL] [Abstract][Full Text] [Related]
38. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
39. Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor.
Nagase K; Kobayashi H; Yoshikawa E; Kurita N
J Mol Graph Model; 2009 Aug; 28(1):46-53. PubMed ID: 19403319
[TBL] [Abstract][Full Text] [Related]
40. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18).
Kanse SM; Matz RL; Preissner KT; Peter K
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2251-6. PubMed ID: 15458976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
